253 related articles for article (PubMed ID: 23201222)
1. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
2. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
[TBL] [Abstract][Full Text] [Related]
4. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
He X; Wang H; Jin T; Xu Y; Mei L; Yang J
PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
[TBL] [Abstract][Full Text] [Related]
5. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.
Haÿ E; Dieudonné FX; Saidak Z; Marty C; Brun J; Da Nascimento S; Sonnet P; Marie PJ
J Cell Physiol; 2014 Nov; 229(11):1765-75. PubMed ID: 24664975
[TBL] [Abstract][Full Text] [Related]
7. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
8. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE; Baylink DJ; Chen J; Mohan S
Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
[TBL] [Abstract][Full Text] [Related]
9. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.
Saidak Z; Haÿ E; Marty C; Barbara A; Marie PJ
Aging Cell; 2012 Jun; 11(3):467-74. PubMed ID: 22321691
[TBL] [Abstract][Full Text] [Related]
11. Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells.
Briolay A; Lencel P; Bessueille L; Caverzasio J; Buchet R; Magne D
Biochem Biophys Res Commun; 2013 Jan; 430(3):1072-7. PubMed ID: 23266365
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1/2 cells.
Hashimoto Y; Kobayashi M; Matsuzaki E; Higashi K; Takahashi-Yanaga F; Takano A; Hirata M; Nishimura F
Cell Biol Int; 2016 Oct; 40(10):1129-36. PubMed ID: 27486054
[TBL] [Abstract][Full Text] [Related]
13. WNT5A induces osteogenic differentiation of human adipose stem cells via rho-associated kinase ROCK.
Santos A; Bakker AD; de Blieck-Hogervorst JM; Klein-Nulend J
Cytotherapy; 2010 Nov; 12(7):924-32. PubMed ID: 20429785
[TBL] [Abstract][Full Text] [Related]
14. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
15. Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells.
Sakisaka Y; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H; Nemoto E
Exp Cell Res; 2015 Aug; 336(1):85-93. PubMed ID: 26112214
[TBL] [Abstract][Full Text] [Related]
16. Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling.
Miraoui H; Severe N; Vaudin P; Pagès JC; Marie PJ
J Cell Biochem; 2010 Aug; 110(5):1147-54. PubMed ID: 20564211
[TBL] [Abstract][Full Text] [Related]
17. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
Liu Y; Rubin B; Bodine PV; Billiard J
J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
[TBL] [Abstract][Full Text] [Related]
19. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
20. Promotion of osteoblast differentiation in mesenchymal cells through Cbl-mediated control of STAT5 activity.
Dieudonne FX; Sévère N; Biosse-Duplan M; Weng JJ; Su Y; Marie PJ
Stem Cells; 2013 Jul; 31(7):1340-9. PubMed ID: 23533197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
